Loading clinical trials...
Loading clinical trials...
An Open-Label, Long-Term Follow Up Study of Safety and Efficacy in PKU Subjects With PAH Deficiency Previously Administered HMI 102
Conditions
Interventions
HMI-102
Locations
2
United States
Boston Children's Hospital
Boston, Massachusetts, United States
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Start Date
August 19, 2020
Primary Completion Date
January 30, 2026
Completion Date
December 1, 2026
Last Updated
June 30, 2022
NCT06628128
NCT05579548
NCT06560736
NCT06332807
NCT06780332
NCT05270837
Lead Sponsor
Homology Medicines, Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions